STOCK TITAN

[Form 4] Penumbra, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Penumbra (PEN) – CEO Adam Elsesser Form 4 filing (23 Jul 2025):

The CEO exercised 27,976 stock options at a $30 strike that were set to expire on 16 Sep 2025, immediately selling 16,150 shares under a pre-arranged Rule 10b5-1 plan at weighted-average prices of $232-$234. After the transactions, his direct ownership increased to 146,258 common shares, while he still holds 577,582 shares through the Siegel/Elsesser Revocable Trust and 83,932 fully vested options.

Proceeds from the sale likely funded the exercise price and tax obligations. The filing does not signal operational changes and leaves the CEO with a substantial equity position, but the market may view the discretionary share sales as a mildly negative sentiment indicator.

Penumbra (PEN) – CEO Adam Elsesser, comunicazione Form 4 (23 lug 2025):

Il CEO ha esercitato 27.976 opzioni su azioni con prezzo di esercizio di 30$, in scadenza il 16 set 2025, vendendo immediatamente 16.150 azioni tramite un piano predefinito secondo la Regola 10b5-1 a prezzi medi ponderati tra 232$ e 234$. Dopo queste operazioni, la sua partecipazione diretta è salita a 146.258 azioni ordinarie, mentre detiene ancora 577.582 azioni tramite il Siegel/Elsesser Revocable Trust e 83.932 opzioni completamente maturate.

I proventi della vendita probabilmente hanno coperto il prezzo di esercizio e le imposte dovute. La comunicazione non indica cambiamenti operativi e lascia il CEO con una posizione azionaria significativa, anche se il mercato potrebbe interpretare queste vendite discrezionali come un leggero segnale negativo.

Penumbra (PEN) – CEO Adam Elsesser, presentación Formulario 4 (23 jul 2025):

El CEO ejerció 27,976 opciones sobre acciones con precio de ejercicio de 30$, que vencían el 16 de sep 2025, vendiendo inmediatamente 16,150 acciones bajo un plan preestablecido conforme a la Regla 10b5-1 a precios promedio ponderados de 232$ a 234$. Tras las transacciones, su propiedad directa aumentó a 146,258 acciones comunes, mientras que aún posee 577,582 acciones a través del Siegel/Elsesser Revocable Trust y 83,932 opciones totalmente consolidadas.

Los ingresos de la venta probablemente financiaron el precio de ejercicio y las obligaciones fiscales. La presentación no indica cambios operativos y mantiene al CEO con una posición accionaria significativa, aunque el mercado podría interpretar estas ventas discrecionales como un indicador de sentimiento ligeramente negativo.

Penumbra (PEN) – CEO Adam Elsesser, Form 4 신고 (2025년 7월 23일):

CEO는 2025년 9월 16일 만료 예정인 행사가 30달러의 스톡옵션 27,976주를 행사하고, 사전 설정된 Rule 10b5-1 계획에 따라 가중평균 가격 232달러에서 234달러 사이에 16,150주를 즉시 매도했습니다. 거래 후 CEO의 직접 보유 주식은 146,258주로 증가했으며, Siegel/Elsesser Revocable Trust를 통해 577,582주와 완전히 권리가 확정된 옵션 83,932주를 추가로 보유하고 있습니다.

매도 수익금은 행사 가격과 세금 납부에 사용된 것으로 보입니다. 이번 신고는 운영상의 변화를 나타내지 않으며, CEO가 상당한 지분을 유지하고 있음을 보여주지만, 시장은 이러한 임의 매도 행위를 다소 부정적인 신호로 해석할 수 있습니다.

Penumbra (PEN) – Formulaire 4 du PDG Adam Elsesser (23 juillet 2025) :

Le PDG a exercé 27 976 options d'achat d'actions à un prix d'exercice de 30$, arrivant à expiration le 16 septembre 2025, vendant immédiatement 16 150 actions dans le cadre d'un plan préétabli selon la règle 10b5-1 à des prix moyens pondérés allant de 232$ à 234$. Après ces transactions, sa détention directe a augmenté à 146 258 actions ordinaires, tandis qu'il détient encore 577 582 actions via le Siegel/Elsesser Revocable Trust et 83 932 options entièrement acquises.

Les produits de la vente ont probablement financé le prix d'exercice et les obligations fiscales. Le dépôt ne signale aucun changement opérationnel et laisse le PDG avec une position en actions importante, bien que le marché puisse percevoir ces ventes discrétionnaires comme un indicateur de sentiment légèrement négatif.

Penumbra (PEN) – CEO Adam Elsesser, Form 4 Einreichung (23. Juli 2025):

Der CEO hat 27.976 Aktienoptionen mit einem Ausübungspreis von 30$ ausgeübt, die am 16. September 2025 ablaufen sollten, und sofort 16.150 Aktien im Rahmen eines vorab vereinbarten Rule 10b5-1 Plans zu einem gewichteten Durchschnittspreis von 232$ bis 234$ verkauft. Nach den Transaktionen erhöhte sich sein Direktbesitz auf 146.258 Stammaktien, während er weiterhin 577.582 Aktien über den Siegel/Elsesser Revocable Trust und 83.932 voll ausgeübte Optionen hält.

Die Erlöse aus dem Verkauf dienten wahrscheinlich zur Finanzierung des Ausübungspreises und der Steuerverpflichtungen. Die Einreichung signalisiert keine operativen Änderungen und belässt den CEO in einer bedeutenden Beteiligungsposition, jedoch könnte der Markt die freiwilligen Aktienverkäufe als leicht negatives Stimmungszeichen werten.

Positive
  • CEO retained 146,258 direct shares and 577,582 trust shares, indicating continued long-term ownership.
  • Use of Rule 10b5-1 plan demonstrates proactive compliance and reduces insider-trading risk.
Negative
  • Sale of 16,150 shares at ~$233 may be interpreted as modest negative sentiment from the CEO.
  • Upcoming option expirations could prompt additional insider selling, adding near-term supply.

Insights

TL;DR: Routine option exercise, partial sale; ownership still high, limited valuation impact.

The $30 strike exercise and concurrent sale at ~$233 realised a conversion spread near $5.6 million, largely offsetting cash outlay and taxes. Because the sales were pre-scheduled via Rule 10b5-1 and the CEO retains over 700k shares (direct + trust) plus 83,932 options, alignment remains. No balance-sheet or guidance implications; liquidity effects are de minimis. I view the filing as neutral for valuation but worth noting for short-term sentiment tracking.

TL;DR: Disclosed 10b5-1 plan mitigates insider-trading concern; governance impact minimal.

The use of a Rule 10b5-1 plan ahead of option expiry shows procedural compliance and reduces litigation exposure. Transparent weighted-average pricing disclosure meets SEC best-practice. Retained holdings suggest continued economic interest, limiting governance risk despite headline ‘insider sell’ perception. Overall, filing is not materially impactful.

Penumbra (PEN) – CEO Adam Elsesser, comunicazione Form 4 (23 lug 2025):

Il CEO ha esercitato 27.976 opzioni su azioni con prezzo di esercizio di 30$, in scadenza il 16 set 2025, vendendo immediatamente 16.150 azioni tramite un piano predefinito secondo la Regola 10b5-1 a prezzi medi ponderati tra 232$ e 234$. Dopo queste operazioni, la sua partecipazione diretta è salita a 146.258 azioni ordinarie, mentre detiene ancora 577.582 azioni tramite il Siegel/Elsesser Revocable Trust e 83.932 opzioni completamente maturate.

I proventi della vendita probabilmente hanno coperto il prezzo di esercizio e le imposte dovute. La comunicazione non indica cambiamenti operativi e lascia il CEO con una posizione azionaria significativa, anche se il mercato potrebbe interpretare queste vendite discrezionali come un leggero segnale negativo.

Penumbra (PEN) – CEO Adam Elsesser, presentación Formulario 4 (23 jul 2025):

El CEO ejerció 27,976 opciones sobre acciones con precio de ejercicio de 30$, que vencían el 16 de sep 2025, vendiendo inmediatamente 16,150 acciones bajo un plan preestablecido conforme a la Regla 10b5-1 a precios promedio ponderados de 232$ a 234$. Tras las transacciones, su propiedad directa aumentó a 146,258 acciones comunes, mientras que aún posee 577,582 acciones a través del Siegel/Elsesser Revocable Trust y 83,932 opciones totalmente consolidadas.

Los ingresos de la venta probablemente financiaron el precio de ejercicio y las obligaciones fiscales. La presentación no indica cambios operativos y mantiene al CEO con una posición accionaria significativa, aunque el mercado podría interpretar estas ventas discrecionales como un indicador de sentimiento ligeramente negativo.

Penumbra (PEN) – CEO Adam Elsesser, Form 4 신고 (2025년 7월 23일):

CEO는 2025년 9월 16일 만료 예정인 행사가 30달러의 스톡옵션 27,976주를 행사하고, 사전 설정된 Rule 10b5-1 계획에 따라 가중평균 가격 232달러에서 234달러 사이에 16,150주를 즉시 매도했습니다. 거래 후 CEO의 직접 보유 주식은 146,258주로 증가했으며, Siegel/Elsesser Revocable Trust를 통해 577,582주와 완전히 권리가 확정된 옵션 83,932주를 추가로 보유하고 있습니다.

매도 수익금은 행사 가격과 세금 납부에 사용된 것으로 보입니다. 이번 신고는 운영상의 변화를 나타내지 않으며, CEO가 상당한 지분을 유지하고 있음을 보여주지만, 시장은 이러한 임의 매도 행위를 다소 부정적인 신호로 해석할 수 있습니다.

Penumbra (PEN) – Formulaire 4 du PDG Adam Elsesser (23 juillet 2025) :

Le PDG a exercé 27 976 options d'achat d'actions à un prix d'exercice de 30$, arrivant à expiration le 16 septembre 2025, vendant immédiatement 16 150 actions dans le cadre d'un plan préétabli selon la règle 10b5-1 à des prix moyens pondérés allant de 232$ à 234$. Après ces transactions, sa détention directe a augmenté à 146 258 actions ordinaires, tandis qu'il détient encore 577 582 actions via le Siegel/Elsesser Revocable Trust et 83 932 options entièrement acquises.

Les produits de la vente ont probablement financé le prix d'exercice et les obligations fiscales. Le dépôt ne signale aucun changement opérationnel et laisse le PDG avec une position en actions importante, bien que le marché puisse percevoir ces ventes discrétionnaires comme un indicateur de sentiment légèrement négatif.

Penumbra (PEN) – CEO Adam Elsesser, Form 4 Einreichung (23. Juli 2025):

Der CEO hat 27.976 Aktienoptionen mit einem Ausübungspreis von 30$ ausgeübt, die am 16. September 2025 ablaufen sollten, und sofort 16.150 Aktien im Rahmen eines vorab vereinbarten Rule 10b5-1 Plans zu einem gewichteten Durchschnittspreis von 232$ bis 234$ verkauft. Nach den Transaktionen erhöhte sich sein Direktbesitz auf 146.258 Stammaktien, während er weiterhin 577.582 Aktien über den Siegel/Elsesser Revocable Trust und 83.932 voll ausgeübte Optionen hält.

Die Erlöse aus dem Verkauf dienten wahrscheinlich zur Finanzierung des Ausübungspreises und der Steuerverpflichtungen. Die Einreichung signalisiert keine operativen Änderungen und belässt den CEO in einer bedeutenden Beteiligungsposition, jedoch könnte der Markt die freiwilligen Aktienverkäufe als leicht negatives Stimmungszeichen werten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Elsesser Adam

(Last) (First) (Middle)
ONE PENUMBRA PLACE

(Street)
ALAMEDA CA 94502

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Penumbra Inc [ PEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO and President
3. Date of Earliest Transaction (Month/Day/Year)
07/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/23/2025 M 27,976 A $30 162,408 D
Common Stock 07/23/2025 S(1) 3,629 D $232.11(2) 158,779 D
Common Stock 07/23/2025 S(1) 8,621 D $233.29(3) 150,158 D
Common Stock 07/23/2025 S(1) 3,900 D $233.86(4) 146,258 D
Common Stock 577,582 I By Trust(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $30 07/23/2025 M 27,976 (6) 09/16/2025 Common Stock 27,976 $0 83,932 D
Explanation of Responses:
1. The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. The Reporting Person entered into the Rule 10b5-1 trading plan in connection with the expiration of certain stock options held by the Reporting Person and related sales of shares to satisfy the exercise price and tax withholding obligations upon the exercise of such stock options.
2. This transaction was executed in multiple trades at prices ranging from $231.60 to $232.49. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
3. This transaction was executed in multiple trades at prices ranging from $232.77 to $233.54. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
4. This transaction was executed in multiple trades at prices ranging from $233.63 to $234.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
5. Shares are held by the Siegel/Elsesser Revocable Trust.
6. All shares are vested and exercisable.
Remarks:
/s/ Stephen Dobson, as attorney-in-fact for Adam Elsesser 07/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Penumbra shares did CEO Adam Elsesser sell on 23-Jul-2025?

He sold 16,150 shares in three tranches under a Rule 10b5-1 plan.

What was the exercise price of the options converted by the CEO?

The options were exercised at a $30 strike price.

What is the CEO's direct shareholding after the transactions?

Adam Elsesser now holds 146,258 common shares directly.

Does the CEO still hold shares indirectly?

Yes, 577,582 shares are held via the Siegel/Elsesser Revocable Trust.

Were the sales pre-planned?

Yes, the transactions were executed under a Rule 10b5-1 trading plan.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

9.04B
37.33M
3.93%
92.35%
3.52%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA